Posted by
ticlopidine, Ticlid (discontinued brand in the US)

ticlopidine, Ticlid (discontinued brand in the US)

What is ticlopidine, and how does it work (mechanism of action)? Ticlopidine is an oral drug that inhibits the ability of platelets to clump and form blood clots. It prevents blood clots by binding to the P2Y12 receptor on platelets, preventing adenosine diphosphate (ADP) from activating platelets. It belongs to a class of drugs called […]

Posted by
Scientists Creating Gene Map of Human ‘Microbiome’

Scientists Creating Gene Map of Human ‘Microbiome’

Latest Digestion News WEDNESDAY, Aug. 14, 2019 (HealthDay News) — The number of genes in bacteria that live in and on people could top 1 billion trillion — and at least half appear to be unique to their host. That mindboggling math comes from scientists at Harvard Medical School and Joslin Diabetes Center in Boston […]

Posted by
Glucovance (glyburide/metformin)

Glucovance (glyburide/metformin)

What is glyburide/metformin tablets, and how does it work (mechanism of action)? Glucovance (glyburide/metformin) is a combination antidiabetic medication containing glyburide and metformin. Glucovance is used to improve blood glucose (sugar) control in adults with type 2 diabetes mellitus. Glyburide is a second generation oral sulfonylurea. It helps to lower blood glucose by stimulating the […]

Posted by
Many Doctors Refusing Care of People Prescribed Opioids

Many Doctors Refusing Care of People Prescribed Opioids

By Serena GordonHealthDay Reporter Latest Chronic Pain News THURSDAY, Aug. 15, 2019 (HealthDay News) — Folks taking opioids for chronic pain may run into trouble if they need to find a new doctor. A new “secret shopper” survey of 194 Michigan primary care clinics found that as many as four out of 10 primary care […]

Posted by
Fewer Opioid Painkillers Can Still Control Surgery Pain

Fewer Opioid Painkillers Can Still Control Surgery Pain

By Amy NortonHealthDay Reporter Latest Chronic Pain News WEDNESDAY, Aug. 14, 2019 (HealthDay News) — Surgery patients can routinely be prescribed fewer opioid pills — even just a handful — without sacrificing their pain relief. That’s what doctors at hospitals in Michigan are reporting after analyzing a statewide effort to curb post-surgery opioid use. In […]

Posted by
Repatha (evolocumab)

Repatha (evolocumab)

What are the side effects of evolocumab? The most common side effects associated with Repatha treatment include Other side effects include diarrhea, muscle pain, muscle spasm, fatigue, urinary tract infections (UTIs), cough, allergic reactions, hypertension, headache, dizziness, joint pain, nausea, confusion, and pancreatitis A more serious side effect is: Hypersensitivity reactions: Repatha should not be […]

Posted by
New Treatments Could Be Powerful Weapons Against Brain Tumors

New Treatments Could Be Powerful Weapons Against Brain Tumors

By Dennis ThompsonHealthDay Reporter Latest Cancer News WEDNESDAY, Aug. 14, 2019 (HealthDay News) — New therapies are showing real promise in fighting the type of brain cancer that claimed the lives of Sens. John McCain and Ted Kennedy, a pair of new clinical trials shows. One experimental treatment injects powerful genes directly into a brain […]

Posted by
America’s Obesity Epidemic May Mean Some Cancers Are Striking Sooner

America’s Obesity Epidemic May Mean Some Cancers Are Striking Sooner

By Alan MozesHealthDay Reporter Latest Cancer News WEDNESDAY, Aug. 14, 2019 (HealthDay News) — Since the turn of the century, American obesity rates have skyrocketed. And now a new study indicates that as the nation’s waistlines expand, cancers long linked to obesity are striking the middle-aged more than ever before. The finding follows a review […]

Posted by
imatinib (Gleevec)

imatinib (Gleevec)

What is imatinib, and how does it work (mechanism of action)? Imatinib is an oral medication used for treating chronic myeloid leukemia and acute lymphoblastic leukemia. It is classified as a kinase inhibitor. Kinase inhibitors include dasatinib (Sprycel), erlotinib (Tarceva), gefitinib (Iressa), nilotinib (Tasigna), pazopanib (Votrient), sunitinib (Sutent), and vandetanib (Caprelsa). Kinase inhibitors prevent tumors […]